Morphine Sulfate
Pricing Report NDC 0054-0404-44

Latest NADAC: $0.31215 per ML · Effective Oct 20, 2021 · Est. package price $9.36 (30 ML)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Morphine Sulfate (NDC 0054-0404-44) is $0.31215 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 20, 2021.

As a provided by Hikma Pharmaceuticals Usa Inc., this medication is distributed in a 30 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.31215
Per ML

Pricing Unit
Per ML Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Oct 20, 2021
Billable Units
30 ML
Estimated Package Price
$9.36
Data Status
As of Oct 27, 2021
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0054-0404-44
Description
30 mL in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.23505 to $0.53911 per ML. Over this 7 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2875 - $0.5391
Market Volatility
87.52% Variance
Latest Trend
0.05%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Oct 20, 2021 $0.40767 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 20, 2021 $0.31215 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 20, 2021 $0.31550 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 22, 2021 $0.40788 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 22, 2021 $0.30650 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 22, 2021 $0.31448 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 18, 2021 $0.47056 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 18, 2021 $0.32050 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 18, 2021 $0.32027 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 21, 2021 $0.38547 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 21, 2021 $0.31276 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 23, 2021 $0.35457 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026